Why the study?
Does angiotensin infusion improve the detection of left ventricular dysfunction during cardiac catheterization in children?
Does angiotensin infusion improve the detection of left ventricular dysfunction during cardiac catheterization in children?
Angiotensin infusion during cardiac catheterization serves as a useful provocative test to unmask latent left ventricular dysfunction in children.
Answers are grounded in this paper and cite their sources.
May support provocative angiotensin testing to unmask latent LV dysfunction in children; hypothesis-generating pending prospective validation.
Response to angiotensin infusion was evaluated in 11 normal children and 24 patients with suspected left ventricular dysfunction. This included 12 patients with endocardial fibroelastosis, three with idiopathic myocardial hypertrophy, one with cardiac glycogenosis, and eight with the Hunter-Hurler syndrome. In 20 of these 24 patients, cardiac catheterization findings confirmed the clinical suspicion of decreased left ventricular function. In 11 instances left ventricular dysfunction was diagnosed by an elevation of resting left ventricular end-diastolic pressure. In eight instances this was ascertained by a decrease in resting left ventricular stroke work when compared to the expected range, derived by using a linear regression formula based on 24 normal subjects. In only four instances were both abnormal; that is, the resting left ventricular stroke work was decreased and the left ventricular end-diastolic pressure was increased. In five of these 20 patients, abnormal left ventricular function was elicited only on infusion of angiotensin. Thus this test is a significant adjunct in our ability to determine myocardial malfunction at cardiac catheterization.
No takes yet. Share an insight, caveat, or question.
Krovetz et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: